The goal of the CRETE Studies is to investigate the newly identified age-dependent heterogeneity in the efficacy of enoxaparin in reducing the risk of central venous catheter-associated deep venous thrombosis in critically ill children.
Deep Venous Thrombosis
The goal of the CRETE Studies is to investigate the newly identified age-dependent heterogeneity in the efficacy of enoxaparin in reducing the risk of central venous catheter-associated deep venous thrombosis in critically ill children.
Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies
-
Children's of Alabama, Birmingham, Alabama, United States, 35233
Children's Hospital Colorado, Aurora, Colorado, United States, 80045
Yale-New Haven Children's Hospital, New Haven, Connecticut, United States, 06520
Johns Hopkins All Children's, Saint Petersburg, Florida, United States, 33701
Children's Hospital of Illinois at OSF Saint Francis Medical Center, Peoria, Illinois, United States, 61637
Stead Family Children's Hospital, Iowa City, Iowa, United States, 52242
Children's Hospital St. Louis, Saint Louis, Missouri, United States, 63110
Hassenfeld Children's Hospital, New York, New York, United States, 10016
New York Presbyterian Hospital, New York, New York, United States, 10065
Golisano Children's Hospital, Rochester, New York, United States, 14642
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
to 17 Years
ALL
No
Yale University,
E. Vincent Faustino, MD, MHS, PRINCIPAL_INVESTIGATOR, Associate Professor of Pediatrics, Yale School of Medicine
2026-07-31